Skip to main content
Công ty Cổ phần Dược phẩm Imexpharm logo

Công ty Cổ phần Dược phẩm Imexpharm — Investor Relations & Filings

Ticker · IMP ISIN · VN000000IMP0 HSX Manufacturing
Open in API
Filings indexed 381 across all filing types
Latest filing 2025-03-04 Regulatory Filings
Country VN Viet Nam
Listing HSX IMP

About Công ty Cổ phần Dược phẩm Imexpharm

www.imexpharm.com

Imexpharm Corporation is a prominent pharmaceutical company with over 48 years of experience in the manufacturing, compounding, and distribution of high-quality pharmaceutical products. The company operates extensive production facilities, including three EU-GMP certified factory clusters and one WHO-GMP certified cluster, making it a leader in EU-GMP compliant manufacturing. Imexpharm is recognized as a top producer of antibiotics and offers a diverse product portfolio encompassing injectable and oral antibiotics, cardiovascular, ophthalmic, musculoskeletal, respiratory, and digestive system treatments, alongside vitamins, minerals, and health protection foods. With 28 product registrations for 11 products in Europe, Imexpharm is dedicated to delivering effective and safe healthcare solutions to the community.

Recent filings

Filing Released Lang Actions
IMP: Thông báo về ngày đăng ký cuối cùng tham dự ĐHĐCĐ thường niên năm 2025
Regulatory Filings Classification · 85% confidence The document is a Vietnamese notice published by the Ho Chi Minh City Stock Exchange regarding the record date (“ngày đăng ký cuối cùng”) for the 2025 Annual General Meeting of Imexpharm’s shareholders. It contains no financial statements or voting results; it is a regulatory/corporate action announcement from the exchange. This does not constitute an AGM presentation, report, or dividend notice; it is a general regulatory announcement, best classified as RNS.
2025-03-04 Vietnamese
IMP: Nghị quyết HĐQT về việc chốt danh sách cổ đông để tổ chức ĐHĐCĐ thường niên năm 2025
Regulatory Filings Classification · 75% confidence The document is a corporate regulatory disclosure announcing the Board of Directors’ resolution to finalize the shareholder list and schedule the 2025 Annual General Meeting. It does not contain any financial statements, audit details, or AGM presentation materials, nor is it reporting voting results or proxy solicitation. It is an official announcement submitted to the State Securities Commission and the Stock Exchange under Vietnamese disclosure rules, which fits best into the general ‘Regulatory Filings’ category (RNS).
2025-02-27 Vietnamese
IMP: Báo cáo tình hình quản trị công ty năm 2024
Governance Information Classification · 92% confidence The document is labeled as “Báo cáo tình hình Quản trị Công ty năm 2024” (Corporate Governance Report for 2024) and contains a full governance report (general company info, shareholder meeting activities, board structure, audit committee, internal regulations, etc.). It is substantive and not merely an announcement of publication or link, and it clearly addresses corporate governance practices and internal rules. This matches the definition of Governance Information (CGR).
2025-01-24 Vietnamese
IMP: Quyết định của HĐQT về việc bổ nhiệm Chủ tịch UB đề cử và lương thưởng
Board/Management Information Classification · 92% confidence The document is a corporate disclosure announcing a Board of Directors’ decision to appoint the Chairperson of the Nomination and Compensation Committee. It details the board decision, effective date, and responsibilities – it is a management change notice, not a financial report or AGM material. Therefore it fits the Board/Management Information category.
2024-11-28 Vietnamese
IMP: CBTT về việc Mephidica không còn là công ty liên kết
Major Shareholding Notification Classification · 75% confidence The document is an irregular disclosure filed on the State Securities Commission and Hochiminh Stock Exchange portals, informing that Imexpharm has transferred its entire 23.56% stake in an associate (Mephydica) and no longer holds any shares. This is a notification of a significant change in share ownership levels (crossing below key thresholds). None of the other categories (e.g., M&A, share issues, treasury transactions) precisely match—this fits the Major Shareholding Notification definition.
2024-11-26 Vietnamese
IMP: Thông báo thay đổi nhân sự - Chủ tịch HĐQT
Board/Management Information Classification · 95% confidence The document is an official securities disclosure filed with the State Securities Commission and Hochiminh Stock Exchange announcing changes in the company’s board of directors (appointment and dismissal of the Chairperson) and related persons. This is a Board/Management Information announcement, corresponding to code MANG.
2024-10-30 Vietnamese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.